Health Technology · Pharmaceuticals: Major · NSE: MAKERSL · data 2026-10-09
Makers Laboratories Ltd
Health check: Strong (6.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹177.07
Market cap
₹107 cr
P/E
30.6
P/B
—
ROE
3.3%
ROCE
7.3%
Debt / equity
0.08
Dividend yield
0.00%
1-year return
7.6%
52-week high
₹236
52-week low
₹150
Operating margin
9.5%
Growth
| Revenue (last 12 months) | ₹148 cr |
| Net profit (last 12 months) | ₹3 cr |
| Sales growth, 3 years (yearly) | 11.5% |
| Profit growth, 3 years (yearly) | — |
Similar companies
Parnax Lab Limited (PARNAXLAB) · Krebs Biochemicals & Industries Ltd. (KREBSBIO) · Alpa Laboratories Limited (ALPA) · Sotac Pharmaceuticals Limited (SOTAC) · Vaishali Pharma Ltd. (VAISHALI)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open MAKERSL in NSE Scanner →